COVID-19 Booster Shot
SEC refuses to recommend COVID-19 booster dose
The COVID-19 booster dose has not been recommended by the Subject Expert Committee (SEC) of CDSCO despite demands
The SEC has also requested more information from The Serum Institute of India (SII) to hold another meeting
In today's meeting SEC reviewed the application of the Serum Institute of India (SII) for the booster dose
The SII had sought authorisation to deliver the booster dosage of its Covishield vaccine amid the introduction of the new COVID variant Omicron and demand
UK's Medicines and Healthcare Products Regulatory Agency has already approved the booster dose of AstraZeneca
In India, many experts have advocated a booster dose, particularly since advent of omnicron. However, the government has yet to make a decision.
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) also stated in a clarification statement that they have never advised a booster dose.